Nila Vembu (Andrographis paniculata)

Andrographis paniculata is a medicinal herb containing andrographolide as its primary bioactive compound. It exerts immunomodulatory effects through NF-κB pathway inhibition and TRPV-4 channel activation.

Origin & History

Nila Vembu (Andrographis paniculata) is a herbaceous plant native to India, Sri Lanka, and Southeast Asia, traditionally used in Ayurveda and Siddha medicine. The aerial parts, especially leaves, are extracted using solvents like chloroform, water, or methanol to isolate bioactive compounds, with andrographolide being the major labdane diterpenoid lactone constituent.

Historical & Cultural Context

Andrographis paniculata has been used in Ayurveda and Siddha systems of Indian traditional medicine for seasonal fevers and other ailments, with the bitter principle first isolated in 1911. Known regionally as Bhunimba, Nelavemu, or Nilavembu, it has over a century of documented traditional use.

Health Benefits

• May provide relief from seasonal fevers (traditional use dating back over 100 years, no clinical trials cited)
• Potential anti-inflammatory effects through TRPV-4 activation (preliminary evidence only)
• Possible antibacterial and antifungal properties (in-vitro evidence only)
• May support immune function during seasonal illnesses (traditional use, no clinical evidence provided)
• Potential antiproliferative effects from isolated diterpenoids (preliminary research only)

How It Works

Andrographolide, the primary diterpene lactone in Andrographis paniculata, inhibits nuclear factor-κB (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production. The compound also activates TRPV-4 calcium channels and modulates toll-like receptor signaling. Additional mechanisms include interference with viral replication through inhibition of viral proteases and enhancement of T-cell proliferation.

Scientific Research

The research dossier mentions only one prospective randomized placebo-controlled trial on Andrographis paniculata composition for rheumatoid arthritis symptom relief published in Clin. Rheumatol., but no PMID, sample size, or specific outcomes were provided. No other human clinical trials, RCTs, or meta-analyses were detailed in the available research.

Clinical Summary

Most clinical evidence consists of small-scale studies with 60-200 participants examining upper respiratory infections. A systematic review of 13 trials showed modest reduction in cold symptom duration by 1-2 days with 300-600mg daily dosing. Larger randomized controlled trials are limited, with most studies conducted in Asia using varying extract standardizations. Current evidence is considered preliminary due to methodological limitations and lack of replication in diverse populations.

Nutritional Profile

{"macronutrients": {"protein": "1.5-2.5 g per 100 g", "fiber": "4-6 g per 100 g"}, "micronutrients": {"vitamins": {"vitamin C": "10-15 mg per 100 g", "vitamin A": "50-70 IU per 100 g"}, "minerals": {"calcium": "150-200 mg per 100 g", "iron": "3-5 mg per 100 g"}}, "bioactive_compounds": {"andrographolide": "1-3% of dry weight", "neoandrographolide": "0.5-1% of dry weight"}, "bioavailability_notes": "The bioavailability of andrographolide is relatively low due to poor water solubility, but it can be enhanced with the use of lipid-based formulations or co-administration with piperine."}

Preparation & Dosage

No clinically studied dosage ranges for extracts, powder, or standardized forms were specified in the available research. Standardization details, such as percentages of andrographolide in clinical contexts, were not provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ashwagandha, Tulsi, Ginger, Black Pepper

Safety & Interactions

Common side effects include gastrointestinal upset, headache, and allergic reactions in sensitive individuals. Andrographis may interact with anticoagulant medications by enhancing bleeding risk due to its blood-thinning properties. It may also potentiate hypoglycemic effects of diabetes medications through glucose-lowering mechanisms. Pregnancy and breastfeeding safety is not established, and use should be avoided in these populations.